Sort
25,944 grants matching “neurodegeneration”
Novel mechanisms of mitochondrial regulation by sirtuin deacetylases
$295,450David Benner Lombard · University Of Michigan At Ann Arbor · R01 · FY2015 · GM
Novel mechanisms of mitochondrial regulation by sirtuin deacetylases
$295,450David Benner Lombard · University Of Michigan At Ann Arbor · R01 · FY2014 · GM
Novel mechanisms of mitochondrial regulation by sirtuin deacetylases
$295,450David Benner Lombard · University Of Michigan At Ann Arbor · R01 · FY2012 · GM
Novel mechanisms of mitochondrial regulation by sirtuin deacetylases
$295,450David Benner Lombard · University Of Michigan At Ann Arbor · R01 · FY2016 · GM
ANIMALS
$295,447Stanley B Prusiner · University Of California, San Francisco · P01 · FY2011 · AG
Mechanisms regulating tau alternative pre-mRNA splicing
$295,431Jane Y Wu · Northwestern University At Chicago · R01 · FY2013 · AG
Ceramide-induced cell death in neurodegeneration
$295,405Erhard Bieberich · Augusta University · R01 · FY2012 · AG
Methamphetamine & Amphetamine Differentially Affect Dopamine Transporter Activity
$295,399Habibeh Khoshbouei · Meharry Medical College · R01 · FY2010 · DA
Cotinine for Cognitive Impairment in Neurological and Neuropsychiatric Disorders
$295,323Alvin V Terry · Augusta University · R01 · FY2009 · AG
Developing neuroprotective strategies for proteinopathy
$295,313Brian C. Kraemer · Seattle Inst For Biomedical/Clinical Res · R01 · FY2017 · NS
Developing neuroprotective strategies for proteinopathy
$295,313Brian C. Kraemer · Seattle Inst For Biomedical/Clinical Res · R01 · FY2016 · NS
Developing neuroprotective strategies for proteinopathy
$295,313Brian C. Kraemer · Seattle Inst For Biomedical/Clinical Res · R01 · FY2018 · NS
Developing neuroprotective strategies for proteinopathy
$295,313Brian C. Kraemer · Seattle Inst For Biomedical/Clinical Res · R01 · FY2015 · NS
Developing neuroprotective strategies for proteinopathy
$295,313Brian C. Kraemer · Seattle Inst For Biomedical/Clinical Res · R01 · FY2014 · NS
Small molecule neuronal autophagy inducers designed to block neurodegeneration to
$295,299Robert Greenhouse · Nanosyn, Inc. · R43 · FY2014 · NS
RNA trafficking in mitochondria
$295,294Carla M. Koehler · University Of California Los Angeles · R01 · FY2012 · GM
Single-molecule characterization of cytoplasmic dynein
$295,285Steven P Gross · University Of California-Irvine · R01 · FY2012 · GM
Regulation of mitochondrial oxidative stress by Bcl-2 family proteins
$295,283Daniel A Linseman · University Of Denver (Colorado Seminary) · R01 · FY2010 · NS
Effects of Conditional GSK3 Knockout on the Pathogenesis of Alzheimers Disease
$295,200Christopher J Phiel · Research Inst Nationwide Children'S Hosp · R01 · FY2009 · AG
Effects of Conditional GSK3 Knockout on the Pathogenesis of Alzheimers Disease
$295,200Christopher J Phiel · Research Inst Nationwide Children'S Hosp · R01 · FY2008 · AG
Single-molecule characterization of cytoplasmic dynein
$295,170Steven P Gross · University Of California-Irvine · R01 · FY2014 · GM
Immune Responsiveness, APOE/Gender in Neurodegeneration
$295,143Carol A Colton · Duke University · R01 · FY2007 · AG
DNA Damage/Repair and Cell Death
$295,142Lee J Martin · Johns Hopkins University · R01 · FY2006 · NS
CORE C: DMSC Core
$295,110Justin Benjamin Miller · Cleveland Clinic Foundation · P20 · FY2022 · GM
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study
$295,100Reisa A. Sperling · Brigham And Women'S Hospital · R01 · FY2020 · AG